Learn About Familial Ventricular Tachycardia

What are the alternative names for Familial Ventricular Tachycardia?
  • Familial ventricular tachycardia
Save information for later
Sign Up
Who are the top Familial Ventricular Tachycardia Local Doctors?
Learn about our expert tiers
Learn more
What are the latest Familial Ventricular Tachycardia Clinical Trials?
Derivation of Human Induced Pluripotent Stem (iPS) Cells to Heritable Cardiac Arrhythmias (Long QT Syndrome, Brugada Syndrome, CPVT and Early Repolarization Syndrome)

Summary: Human induced pluripotent stem cells (hiPSCs) have driven a paradigm shift in the modeling of human disease; the ability to reprogram patient-specific cells holds the promise of an enhanced understanding of disease mechanisms and phenotypic variability, with applications in personalized predictive pharmacology/toxicology, cell therapy and regenerative medicine. This research will collect blood or ...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Prevention of Stroke and Sudden Cardiac Death by Recording of 1-Channel Electrocardiograms

Summary: Single-channel electrocardiograms (lead I of 12-lead surface ECG; 30 seconds) will be collected from subjects/patients at 11 clinical centers in Germany to train an Artificial Intelligence in the automatic diagnosis of regular and irregular heart rhythms. Heart rhythms of interest are normal sinus rhythm (SR), atrial fibrillation (AF), atrial premature beats (APBs), ventricular premature beats (VP...

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center

What are the Latest Advances for Familial Ventricular Tachycardia?
Outcomes of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia Treated With β-Blockers.
Cardiac sympathetic denervation in the prevention of genetically mediated life-threatening ventricular arrhythmias.
Tired of the same old research?
Check Latest Advances
Bilateral cardiac sympathetic denervation for refractory arrhythmia in an individual with catecholaminergic polymorphic ventricular tachycardia associated with T-cell-mediated ganglionitis.